OvalOVAL Corporation7727東証スタンダード精密機器FY ending Mar 2026, consolidated, J-GAAP

Oval revenue and profit

Out of every ¥100 of sales, about ¥11 is left as operating profit. Revenue changed +3.6% from the prior year, operating profit +19.7%.

Five-year trend

Revenue¥15.6B
FY ending Mar 2022: ¥11.1B¥11.1BFY ending Mar 2023: ¥13.3B¥13.3BFY ending Mar 2024: ¥14.3B¥14.3BFY ending Mar 2025: ¥15B¥15BFY ending Mar 2026: ¥15.6B¥15.6BFY22FY23FY24FY25FY26
Operating income¥1.7B
FY ending Mar 2022: ¥276.9M¥276.9MFY ending Mar 2023: ¥1.11B¥1.11BFY ending Mar 2024: ¥1.48B¥1.48BFY ending Mar 2025: ¥1.42B¥1.42BFY ending Mar 2026: ¥1.7B¥1.7BFY22FY23FY24FY25FY26
Operating margin10.9%
FY ending Mar 2022: 2.5%2.5%FY ending Mar 2023: 8.3%8.3%FY ending Mar 2024: 10.3%10.3%FY ending Mar 2025: 9.5%9.5%FY ending Mar 2026: 10.9%10.9%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin9.0%
Asset turnover0.63×
ROA5.7%
ROA5.7%
Financial leverage2.18×
ROE12.4%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin9.0%
2022: 2.6%2.6%2023: 4.9%4.9%2024: 7.7%7.7%2025: 6.8%6.8%2026: 9.0%9.0%2223242526
Asset turnover0.63×
2022: 0.51×0.51×2023: 0.60×0.60×2024: 0.63×0.63×2025: 0.63×0.63×2026: 0.63×0.63×2223242526
ROA5.7%
2022: 1.3%1.3%2023: 2.9%2.9%2024: 4.8%4.8%2025: 4.3%4.3%2026: 5.7%5.7%2223242526
Financial leverage2.18×
2022: 2.31×2.31×2023: 2.28×2.28×2024: 2.22×2.22×2025: 2.16×2.16×2026: 2.18×2.18×2223242526
ROE12.4%
2022: 3.0%3.0%2023: 6.7%6.7%2024: 10.7%10.7%2025: 9.3%9.3%2026: 12.4%12.4%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20222.6%0.51×1.3%2.31×3.0%
20234.9%0.60×2.9%2.28×6.7%
20247.7%0.63×4.8%2.22×10.7%
20256.8%0.63×4.3%2.16×9.3%
20269.0%0.63×5.7%2.18×12.4%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue63.3%
2021: 85.7%85.7%2022: 79.3%79.3%2023: 65.5%65.5%2024: 61.0%61.0%2025: 59.6%59.6%2026: 63.3%63.3%212223242526
PPE ÷ total assets39.9%
2021: 40.1%40.1%2022: 40.7%40.7%2023: 39.0%39.0%2024: 37.3%37.3%2025: 36.6%36.6%2026: 39.9%39.9%212223242526
Goodwill ÷ parent equity1.6%
2021: 5.2%5.2%2022: 4.5%4.5%2023: 3.6%3.6%2024: 2.8%2.8%2025: 2.1%2.1%2026: 1.6%1.6%212223242526
Goodwill balance¥180.4M
2021: ¥481.1M¥481.1M2022: ¥421M¥421M2023: ¥360.8M¥360.8M2024: ¥300.7M¥300.7M2025: ¥240.5M¥240.5M2026: ¥180.4M¥180.4M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥479.3M
2021: ¥419.8M¥419.8M2022: ¥418.4M¥418.4M2023: ¥457.5M¥457.5M2024: ¥519.2M¥519.2M2025: ¥499M¥499M2026: ¥479.3M¥479.3M212223242526
R&D / revenue3.1%
2021: 4.1%4.1%2022: 3.8%3.8%2023: 3.4%3.4%2024: 3.6%3.6%2025: 3.3%3.3%2026: 3.1%3.1%212223242526
Receivable days—
2021: 118d118d212223242526
Payable days23d
2021: 31d31d2022: 34d34d2023: 34d34d2024: 33d33d2025: 32d32d2026: 23d23d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue11,14513,31314,34815,04915,589
Cost of revenue7,0608,0358,3968,9168,939
Gross profit4,0855,2785,9526,1336,650
SG&A3,8084,1734,4764,7104,947
Operating income2771,1051,4761,4231,703
Pretax income5091,0201,5511,4221,762
Income tax220338417384325
Net income attributable to owners2866491,1021,0301,400
Operating margin2.5%8.3%10.3%9.5%10.9%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 14%
Property, plant and equipment 40%
2%
3%
Other assets 41%

Funding

2%
Other liabilities 32%
Equity 66%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥3.19B¥2.96B¥3.2B¥3.85B¥3.42B
Total assets¥21.7B¥22.4B¥23.5B¥24.5B¥24.7B
Net assets¥13.5B¥14.3B¥15.4B¥16.3B¥16.2B
Share capital¥2.2B¥2.2B¥2.2B¥2.2B¥2.2B
Property, plant and equipment¥8.83B¥8.73B¥8.75B¥8.97B¥9.86B
Intangible assets excluding goodwill¥722.1M¥606.7M¥474.4M¥383.1M¥291.5M
Goodwill¥421M¥360.8M¥300.7M¥240.5M¥180.4M
Investment securities¥250.6M¥285.7M¥355.9M¥402.3M¥703.2M
Current assets¥10.7B¥11.5B¥12.6B¥13.5B¥12.4B
Current liabilities¥3.78B¥3.99B¥4.32B¥4.55B¥4.21B
Trade payables¥658.3M¥752M¥755.4M¥785M¥551.7M
Short-term borrowings¥1.3B¥1.41B¥1.31B¥1.26B¥1.21B
Long-term borrowings¥1.08B¥714.2M¥507.3M¥361.4M¥1.13B
Total liabilities¥8.17B¥8.08B¥8.09B¥8.17B¥8.5B
Non-controlling interests¥368.5M¥417.3M¥452.4M¥455.1M¥472.3M
Equity attributable to owners of parent¥9.4B¥9.89B¥10.7B¥11.4B¥11.1B
Retained earnings¥5.46B¥5.96B¥6.79B¥7.51B¥8.49B
Treasury stock-¥403M-¥403M-¥403M-¥403M-¥187.1M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第104期(2025/04/01-2026/03/31)

    ID S100YDYH2026-06-19Open
  • EDINET (FSA Japan)

    有価証券報告書-第103期(2024/04/01-2025/03/31)

    ID S100W6CO2025-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第102期(2023/04/01-2024/03/31)

    ID S100TTKF2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2022/04/01-2023/03/31)

    ID S100R60A2023-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(令和3年4月1日-令和4年3月31日)

    ID S100OH5Z2022-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(令和2年4月1日-令和3年3月31日)

    ID S100LPBW2021-06-25Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.